- Latest available (Revised)
- Original (As adopted by EU)
Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (Text with EEA relevance)
After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.
The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.
There are outstanding changes not yet made to Commission Regulation (EU) No 283/2013. Those changes will be listed when you open the content using the Table of Contents below. Any changes that have already been made to the legislation appear in the content and are referenced with annotations.
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the affected provisions when you open the content using the Table of Contents below.
Article 3.Transitional measures as regards procedures concerning active substances
Article 4.Transitional measures as regards procedures concerning plant protection products
INTRODUCTION Information to be submitted, its generation and its presentation
1. The information submitted shall meet the following requirements.
1.1. The information shall be sufficient to evaluate the foreseeable risks,...
1.2. Any information on potentially harmful effects of the active substance,...
1.3. Any information on potentially unacceptable effects of the active substance,...
1.4. The information shall include all relevant data from the scientific...
1.5. The information shall include a full and unbiased report of...
1.6. The simultaneous use of the active substance as a biocide...
1.7. Where relevant, the information shall be generated using test methods,...
1.8. The information shall include a full description of the test...
1.9. The information shall include a list of endpoints for the...
1.10. Where relevant, the information shall be generated in accordance with...
1.11. The information on the active substance, taken together with the...
1.12. Where relevant, tests shall be designed and data analysed using...
1.13. Exposure calculations shall refer to scientific methods accepted by the...
1.14. For each section of the data requirements, a summary of...
2. The requirements set out in this Regulation shall represent the...
4.1. A detailed description (specification) of the material used shall be...
4.2. Where studies are conducted using an active substance produced in...
4.3. Where studies are conducted using an active substance of different...
4.5. When tests shall be conducted using purified active substance (≥...
4.6. Where radio-labelled test material is used, radio-labels shall be positioned...
5. Tests on vertebrate animals
5.1. Tests on vertebrate animals shall be undertaken only where no...
5.2. The principles of replacement, reduction and refinement of the use...
5.3. Tests involving the deliberate administration of the active substance or...
5.4. For ethical reasons, study designs shall be carefully considered, taking...
6. For purposes of information and of harmonisation the list of...
PART A CHEMICAL ACTIVE SUBSTANCES
SECTION 2 Physical and chemical properties of the active substance
SECTION 5 Toxicological and metabolism studies
1. The relevance of generating toxicity data in animal models with...
2. All potentially adverse effects found during toxicological investigations (including effects...
3. Where available, historical control data shall be provided routinely. The...
4. When preparing a study plan, available data on the test...
5. For all studies actual achieved dose in mg/kg body weight,...
6. The analytical methods to be used in toxicity studies shall...
7. Where, as a result of metabolism or other processes in...
9. For dose selection, toxicokinetic data such as saturation of absorption...
5.1. Studies on absorption, distribution, metabolism and excretion in mammals
SECTION 7 Fate and behaviour in the environment
SECTION 8 Ecotoxicological studies
1. All available biological data and information which is relevant to...
2. The ecotoxicological assessment shall be based on the risk that...
3. It may be necessary to conduct separate studies for metabolites,...
5. The potential impact of the active substance on biodiversity and...
8. In order to facilitate the assessment of the significance of...
9. Higher tier studies shall be designed and data analysed using...
10. Pending the validation and adoption of new studies and of...
8.7. Effects on other terrestrial organisms (flora and fauna)
PART B MICRO-ORGANISMS INCLUDING VIRUSES
(i) Active substances are defined in Article 2(2) of Regulation (EC)...
(ii) For all micro-organisms that are subject to application all available...
(iii) Pending the acceptance of specific guidelines at international level, the...
(iv) Where testing is done, a detailed description (specification) of the...
(v) Where the micro-organism has been genetically modified, a copy of...
(vi) Where relevant, data shall be analysed using appropriate statistical methods....
(vii) In the case of studies in which dosing extends over...
1. IDENTITY OF THE MICRO-ORGANISM
1.3. Name and species description, strain characterisation
(i) The micro-organism should be deposited at an internationally recognised culture...
(ii) Each micro-organism that is subject to the application shall be...
(iii) Best available technology should be used to identify and characterise...
(iv) Common name or alternative and superseded names and code names...
1.4. Specification of the material used for manufacturing of formulated products...
3. FURTHER INFORMATION ON THE MICRO-ORGANISM
(i) The information provided must describe the intended purposes for which...
(ii) The information provided must specify the normal methods and precautions...
(iii) The studies, data and information submitted, must demonstrate the suitability...
(iv) The information and data referred to are required for each...
3.5. Information on the occurrence or possible occurrence of the development...
3.6. Methods to prevent loss of virulence of seed stock of...
3.7. Recommended methods and precautions concerning handling, storage, transport or fire...
(i) Available information based on the properties of the micro-organism and...
(ii) The information provided, taken together with that provided for one...
(iii) All effects found during investigations shall be reported. Investigations which...
(iv) For all studies actual achieved dose in colony forming units...
(v) Evaluation of the micro-organism shall be carried out in a...
5.6. Summary of mammalian toxicity, pathogenicity and infectiveness and overall evaluation...
7. FATE AND BEHAVIOUR IN THE ENVIRONMENT
(i) Information on the origin, the properties, and the survival of...
(ii) The information provided, taken together with other relevant information, and...
(iii) In particular, the information provided shall be sufficient to:
(iv) Any relevant metabolites (i.e. of concern for human health and/or...
(v) Available information on the relationship with naturally occurring wild type...
(vi) Before performing studies as referred to below, the applicant shall...
8. EFFECTS ON NON-TARGET ORGANISMS
(i) The information on identity, biological properties and further information in...
(ii) The choice of the appropriate non-target organisms for testing of...
(iii) The information provided, taken together with that for one or...
(iv) In particular, the information provided for the micro-organism, together with...
(v) There is a need to report all potentially adverse effects...
(vi) For all studies, average achieved dose in cfu/kg body weight...
(vii) It may be necessary to conduct separate studies for relevant...
(viii) In order to facilitate the assessment of the significance of...
(ix) Tests must be performed unless it can be justified that...
The Whole Regulation you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: